Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

How to establish new clinical protocols: learnings from COVID-19

Article-How to establish new clinical protocols: learnings from COVID-19

Omnia Health Live America speakers reveal hospital decision-making successes and flaws in the pandemic in Brazil.

The first day of Omnia Health Live Americas was packed with quality content. Closing the evening of 2 November, the debate How to establish new clinical protocols: learnings from COVID-19, moderated by Felipe Reis, from Hospital Beneficencia Portuguesa de Sao Paulo (BP), addressed the work of hospitals since the beginning of COVID-19, when it was still an unknown disease.

The session was moderated by Miguel Cendoroglo, Superintendent of Hospital Albert Einstein, and counted on the participation of Emerson Gasparetto, CMO of Rede Impar; Felipe Reis, executive manager of Innovation, Technology and Medical Solutions at BP; and Pedro Batista, executive director Prevent Senior. 

Cendoroglo recalled that there was a real "obsession" with the quality of processes and prepardeness since January, when Albert Einstein Hospital had been following the disease through research. "This overkill brought us greater peace of mind when dealing with the problem," said the superintendent. "One issue for example was beds, that had reached 85% occupancy, but we managed to avoid the problem of running out of them," he recalled. 

Albert Einstein was the first hospital to have received the first confirmed coronavirus patient with coronavirus in Brazil. Regarding negative aspects, all agreed with the inadequate way in which the information was passed on to both patients and clinical staff.

“Our scientific validation system is very flawed. At DASA [medical diagnostics company], a crisis committee was made where decisions were made and nothing was done without the approval of the scientific committee ”, highlighted Gasparetto. "An example was the failure to launch the rapid test, which did not meet the group's technical criteria," explained the executive.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.